[Indications for and clinical efficacy of continuous hemodiafiltration (CHDF) for severe acute pancreatitis]

Nihon Rinsho. 2004 Nov;62(11):2094-100.
[Article in Japanese]

Abstract

It has been claimed humoral mediator network including pro-inflammatory cytokines plays a pivotal role in the pathophysiology of SAP. On the other hands, we have reported CHDF using polymethyl methacrylate (PMMA) membrane hemofilter could remove cytokines in blood of a patient continuously and effectively. Therefore, we applied CHDF to patients with SAP. CHDF was performed using a PMMA-hemofilter for removal of causative cytokines regardless of renal function 24 hours a day without interruption until IL-6 blood level became below 400 pg/ml. Selective digestive decontamination (SDD) was also given for prevention of bacterial translocation. Forty-two out of 45 patients (93%) receiving both CHDF and SDD survived. We conclude critical care with PMMA-CHDF and SDD is an effective treatment for SAP.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Acute Disease
  • Animals
  • Bacterial Translocation
  • Biomarkers / blood
  • Cytokines / isolation & purification
  • Decontamination / methods
  • Hemodiafiltration / methods*
  • Humans
  • Inflammation Mediators / isolation & purification
  • Interleukin-6 / blood
  • Interleukin-6 / isolation & purification
  • Pancreatitis / diagnosis
  • Pancreatitis / etiology
  • Pancreatitis / therapy*
  • Polymethyl Methacrylate
  • ROC Curve
  • Severity of Illness Index

Substances

  • Biomarkers
  • Cytokines
  • Inflammation Mediators
  • Interleukin-6
  • Polymethyl Methacrylate